June Jobs Data Puts Focus on Healthcare ETFs & Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 07 2025
0mins
Source: NASDAQ.COM
U.S. Job Market Overview: Nonfarm payrolls increased by 147,000 in June 2025, with the unemployment rate decreasing to 4.1%, indicating labor market stability despite a slight decline in the overall labor force.
Healthcare Sector Insights: The healthcare sector added 39,000 jobs in June, with ETFs like Health Care Select Sector SPDR ETF (XLV) and iShares U.S. Healthcare Providers ETF (IHF) highlighted for potential investment opportunities amidst ongoing changes in healthcare coverage.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OHI
Wall Street analysts forecast OHI stock price to rise
9 Analyst Rating
4 Buy
5 Hold
0 Sell
Moderate Buy
Current: 46.070
Low
42.00
Averages
46.44
High
50.00
Current: 46.070
Low
42.00
Averages
46.44
High
50.00
About OHI
Omega Healthcare Investors, Inc. is a real estate investment trust (REIT). The Company operates through a single segment, which invests in healthcare-related real estate properties located in the United States and the United Kingdom. Its core business is to provide financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities (SNFs), assisted living facilities (ALFs), and to a lesser extent, independent living facilities (ILFs), rehabilitation and acute care facilities (specialty facilities) and medical office buildings (MOBs). Its core portfolio consists of its long-term leases and real estate loans with healthcare operating companies and affiliates. In addition, the Company makes loans to operators and/or their principals. The Company's portfolio of real estate investments includes over 1,026 healthcare facilities, located in 42 states and the United Kingdom that are operated by 87 third-party operators.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
Omega Healthcare Reports Strong Q1 Earnings Despite Stock Decline
- Earnings Beat: Omega Healthcare Investors reported adjusted funds from operations (FFO) of $0.82 per diluted share for Q1, up from $0.75 a year ago and exceeding the consensus estimate of $0.79, indicating improved operational efficiency.
- Significant Revenue Growth: The company's revenue for the first quarter reached $322.96 million, up from $276.79 million a year earlier and surpassing the average analyst estimate of $266.71 million, reflecting strong market performance.
- Upgraded FFO Guidance: Omega now expects adjusted FFO per share for 2026 to be in the range of $3.19 to $3.25, an increase from the previous guidance of $3.15 to $3.25, demonstrating confidence in future performance.
- Stable Rent Payments: Despite Genesis Healthcare's bankruptcy protection, Omega anticipates it will continue to pay its contractual rent obligations of $13.3 million per quarter, while Maplewood Senior Living paid $19.4 million in rent this quarter, indicating tenant stability supporting the company's finances.
See More
Omega Healthcare Investors Declares Cash Dividend of $0.67
- Dividend Declaration: Omega Healthcare Investors, Inc. has declared a cash dividend of $0.67 per share, payable on May 15, 2026, which aims to provide shareholders with a stable return and enhance investor confidence in the company.
- Record Date for Shareholders: The record date for this dividend is set for May 4, 2026, ensuring that shareholders who own stock by this date will receive the dividend, thereby promoting stability in shareholder ownership.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, which highlights its strategic positioning and market focus in the healthcare sector.
- Diverse Asset Portfolio: The company's asset portfolio spans various healthcare companies across the US, UK, and Canada, utilizing a triple-net lease structure, demonstrating its market penetration capabilities and risk diversification strategy across different regions.
See More
BofA Downgrades Omega Healthcare Amid Competition and Regulatory Risks
- Rating Downgrade: BofA Securities has downgraded Omega Healthcare Investors (OHI) from Neutral to Underperform, with the price target reduced from $52 to $46, reflecting the company's vulnerability amid heightened competition and regulatory risks, which is expected to negatively impact the stock price.
- Earnings Forecast Adjustment: Analysts have lowered the FY26 AFFO estimate to a multiple of 15.0x from 16.5x, indicating a pessimistic outlook on the company's future earnings, which may lead to a decline in investor confidence.
- Acquisition Capability Weakening: Due to OHI's larger market capitalization, analysts have cut the FY26 acquisition volume assumption from $929 million to $633 million, indicating that OHI faces greater challenges in a competitive market and struggles to enhance earnings through acquisitions.
- Increased Regulatory Risks: Analysts noted that while the SNF subsector benefits from favorable demographic trends, it faces elevated regulatory and public reimbursement risks, which could pressure tenant coverage and result in downward pressure on OHI's valuation.
See More
Oversold Signals Emerge in Large-Cap Stocks
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
Omega Healthcare Q1 2026 Earnings Highlights
- Strong Financial Performance: Omega Healthcare reported an adjusted funds from operations (AFFO) of $0.82 per share for Q1 2026, reflecting a year-over-year increase driven by acquisitions and active portfolio management, thereby enhancing the company's financial stability and market competitiveness.
- Capital Recycling Strategy: The company plans to complete $480 million in asset sales in Q2, a move that not only boosts liquidity but is also expected to generate approximately $0.03 of annual AFFO and FAD accretion, demonstrating flexibility in capital operations.
- Significant Revenue Growth: Q1 revenue reached $323 million, a 16.6% increase from $277 million in Q1 2025, indicating strong performance in the market and rising customer demand, further solidifying its position in the healthcare investment sector.
- Optimistic Outlook: The company narrowed its full-year adjusted AFFO guidance to a range of $3.19 to $3.25 per share, reflecting a $0.02 increase over the midpoint of previous guidance, showcasing management's confidence in future performance while acknowledging increased market competition and investment opportunities.
See More
Omega Healthcare Reports Increased Q1 Profit
- Profit Growth: Omega Healthcare Investors Inc. reported a first-quarter profit of $151.05 million, translating to $0.47 per share, which marks a significant increase from last year's $109.03 million and $0.33 per share, indicating strong performance in the healthcare investment sector.
- Revenue Increase: The company's revenue rose by 16.7% year-over-year to $322.96 million, up from $276.79 million last year, reflecting enhanced competitiveness and growing customer demand in the market.
- Financial Health: With continuous revenue growth and improved profitability, Omega Healthcare's financial condition has strengthened, enhancing its market position in healthcare investments and potentially attracting more investor interest.
- Market Outlook: As the healthcare industry continues to evolve, Omega Healthcare's profit and revenue growth provide a solid foundation for future expansion and investment, signaling the company's long-term growth potential within the sector.
See More
Omega Healthcare Reports Strong Q1 Earnings Despite Stock Decline
- Earnings Beat: Omega Healthcare Investors reported adjusted funds from operations (FFO) of $0.82 per diluted share for Q1, up from $0.75 a year ago and exceeding the consensus estimate of $0.79, indicating improved operational efficiency.
- Significant Revenue Growth: The company's revenue for the first quarter reached $322.96 million, up from $276.79 million a year earlier and surpassing the average analyst estimate of $266.71 million, reflecting strong market performance.
- Upgraded FFO Guidance: Omega now expects adjusted FFO per share for 2026 to be in the range of $3.19 to $3.25, an increase from the previous guidance of $3.15 to $3.25, demonstrating confidence in future performance.
- Stable Rent Payments: Despite Genesis Healthcare's bankruptcy protection, Omega anticipates it will continue to pay its contractual rent obligations of $13.3 million per quarter, while Maplewood Senior Living paid $19.4 million in rent this quarter, indicating tenant stability supporting the company's finances.
See More
Omega Healthcare Investors Declares Cash Dividend of $0.67
- Dividend Declaration: Omega Healthcare Investors, Inc. has declared a cash dividend of $0.67 per share, payable on May 15, 2026, which aims to provide shareholders with a stable return and enhance investor confidence in the company.
- Record Date for Shareholders: The record date for this dividend is set for May 4, 2026, ensuring that shareholders who own stock by this date will receive the dividend, thereby promoting stability in shareholder ownership.
- Investment Focus: As a real estate investment trust, Omega focuses on the long-term healthcare industry, primarily investing in skilled nursing and assisted living facilities, which highlights its strategic positioning and market focus in the healthcare sector.
- Diverse Asset Portfolio: The company's asset portfolio spans various healthcare companies across the US, UK, and Canada, utilizing a triple-net lease structure, demonstrating its market penetration capabilities and risk diversification strategy across different regions.
See More
BofA Downgrades Omega Healthcare Amid Competition and Regulatory Risks
- Rating Downgrade: BofA Securities has downgraded Omega Healthcare Investors (OHI) from Neutral to Underperform, with the price target reduced from $52 to $46, reflecting the company's vulnerability amid heightened competition and regulatory risks, which is expected to negatively impact the stock price.
- Earnings Forecast Adjustment: Analysts have lowered the FY26 AFFO estimate to a multiple of 15.0x from 16.5x, indicating a pessimistic outlook on the company's future earnings, which may lead to a decline in investor confidence.
- Acquisition Capability Weakening: Due to OHI's larger market capitalization, analysts have cut the FY26 acquisition volume assumption from $929 million to $633 million, indicating that OHI faces greater challenges in a competitive market and struggles to enhance earnings through acquisitions.
- Increased Regulatory Risks: Analysts noted that while the SNF subsector benefits from favorable demographic trends, it faces elevated regulatory and public reimbursement risks, which could pressure tenant coverage and result in downward pressure on OHI's valuation.
See More
Oversold Signals Emerge in Large-Cap Stocks
- Oversold Stock List: The Relative Strength Index (RSI) screening highlights Sysco Corporation (SYY) at the top with an RSI of 24, indicating significant oversold signals and a market capitalization of $34.11 billion, suggesting potential undervaluation and rebound opportunities.
- Sector Distribution: Following closely is Boston Scientific Corporation (BSX) with an RSI of 25 and a market cap of $93.26 billion, reflecting intense selling pressure across sectors such as healthcare and consumer staples, which may present value investment opportunities for investors.
- Other Notable Oversold Stocks: McCormick & Company (MKC), Cintas Corporation (CTAS), and Universal Health Services (UHS) rank in the top five with RSI values of 26 and 27, and market caps of $13.54 billion, $67.66 billion, and $10.93 billion respectively, highlighting their vulnerability in the current market environment.
- Market Pressure Analysis: All stocks in the top ten list maintain an RSI below 30, indicating high selling pressure across sectors including medical facilities, retail, and real estate, prompting investors to monitor these oversold stocks for potential rebound opportunities amidst market volatility.
See More
